^
    Back
    Association details:
    Biomarker:SET-NUP214 fusion
    Cancer:T Acute Lymphoblastic Leukemia
    Regimen: (etoposide IV + daunorubicin + cytarabine)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    Source:
    Front Oncol
    Title:

    Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review

    Published date:
    03/26/2021
    Excerpt:
    Here, we present the treatment process of an illuminating case of T-ALL with SET-CAN/NUP214 fusion….The patient received DAE regimen chemotherapy, and finally achieved complete remission and received allogenic hematopoietic stem cell transplantation (allo-HSCT).
    DOI:
    10.3389/fonc.2021.651494